Checkpoint Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '25 Jul 29, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	1,029	393	765	581	236
Market Cap Growth	-48.57%	-48.57%	31.75%	146.32%	-
Enterprise Value	1,030	398	769	582	244
Last Close Price	40.10	19.03	36.91	42.02	17.06
PE Ratio	44.07	20.81	18.23	14.71	13.09
PS Ratio	9.55	3.65	6.03	5.10	3.77
PB Ratio	2.40	0.92	1.86	6.21	4.36
P/TBV Ratio	2.40	0.92	1.86	6.21	4.36
P/FCF Ratio	27.84	10.64	-	-	-
P/OCF Ratio	23.75	9.08	-	-	-
EV/Sales Ratio	9.55	3.69	6.07	5.11	3.90
EV/EBITDA Ratio	31.64	12.21	10.78	10.37	9.65
EV/EBIT Ratio	34.31	13.24	12.46	10.55	9.79
EV/FCF Ratio	27.85	10.75	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.44	0.14
Debt / EBITDA Ratio	0.32	0.32	0.22	0.73	0.29
Debt / FCF Ratio	0.28	0.28	-	-	-
Asset Turnover	0.24	0.24	0.41	1.00	-
Inventory Turnover	0.93	0.93	1.12	2.08	-
Quick Ratio	4.36	4.36	2.48	1.39	2.21
Current Ratio	16.95	16.95	8.57	2.17	4.41
Return on Equity (ROE)	4.50%	4.50%	16.62%	53.52%	-
Return on Assets (ROA)	4.13%	4.13%	12.54%	30.38%	-
Return on Capital (ROIC)	4.33%	4.33%	13.72%	35.18%	-
Return on Capital Employed (ROCE)	7.00%	7.00%	15.00%	58.40%	45.30%
Earnings Yield	1.84%	4.81%	5.49%	6.80%	7.64%
FCF Yield	3.59%	9.40%	-31.29%	-4.43%	-33.26%
Dividend Yield	0.25%	-	0.27%	-	-
Payout Ratio	10.93%	10.94%	-	-	-
Buyback Yield / Dilution	-10.14%	-10.14%	-52.04%	-	-
Total Shareholder Return	-9.89%	-10.14%	-51.77%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.